BLACK WEEKSLiekovky −15 % · kity −10 % · ostatné −5 %s kódomDoprava po Nemecku zadarmo od 200 €

Táto stránka bola preložená automaticky a môže obsahovať chyby. Ste rodený hovoriaci? Radi privítame vašu spätnú väzbu a opravy.Poslať spätnú väzbu

The Peptide Desk The Peptide Desk
Retatrutide, fotografia produktu

7 laboratórnych správ

PDF
99%
Čistota
Testované
Retatrutide 10mg
Laboratórium
Analiza Białek
Dátum
November 2026
Výsledok
99% purity (10.37 mg measured)
Endotoxíny
5.54 EU/vial
Č. objednávky
Heslo

Testované nezávisle, overiteľné heslom priamo v laboratóriu.

GLP-1

Retatrutide

GLP-1

Objednávka

Cena za kus - Doprava po Nemecku zadarmo od 200 € počas Black Weeks
  • DHL so sledovaním zásielky
  • Diskrétne balenie

4.6 z 5 na Trustpilote73 hodnotení

Hľadané aj ako: Retatrutid · Reta · LY3437943

V skratke

Retatrutide v číslach

Kľúčové údaje z nášho lexikónu. Posuňte bod po krivke a uvidíte, koľko podľa výpočtu zostáva po jednej dávke.

Celé heslo v lexikóne

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~6 days

Half-life ~6 days
After 12 days: 25 %
Day 650 %Day 7, next dose45 %Day 1225 %Day 1812.5 %Day 303.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

~6days

Class
Triple agonistGLP-1 / GIP / glucagon
Frequency
Once weeklysubcutaneous
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 60 mg11 sizes in the shop

Znalosti

Všetko o Retatrutide

Podrobné informácie pripravujeme.

Hodí sa priobjednať

Čo k tomu potrebujete

Bakteriostatická voda sa do košíka pridá automaticky. Striekačky a tampóny jedným kliknutím.

Inzulínové striekačky

10 ks · 5.50 €

Alkoholové tampóny

50 ks · 10 €

Koľko vody?

Jednotky na striekačke pre vašu veľkosť liekovky.

Otvoriť kalkulačku →

FAQ

Časté otázky

Zdroje ku každej odpovedi: heslo v lexikóne

Máte ešte otázku?

Napíšte nám, náš tím vám pomôže.

Is Retatrutide approved?

No, as of 25 October 2026 there is no approval. Retatrutide is in phase 3: 14 phase 3 trials are listed on ClinicalTrials.gov, five of them completed. The first phase 3 results were published in 2026.

How does Retatrutide differ from Tirzepatide and Semaglutide?

The number of receptors. Semaglutide acts only on the GLP-1 receptor, Tirzepatide on GLP-1 and GIP. Retatrutide also targets the glucagon receptor. In animal models this added higher energy expenditure. A head-to-head trial against Tirzepatide is still running (TRIUMPH-5).

What did the phase 3 trials show?

In TRIUMPH-1 (obesity without diabetes) weight fell by 25.0 percent on average after 80 weeks at the highest study dose, by 3.9 percent on placebo. In TRIUMPH-2 (with type 2 diabetes) it was 18.8 versus 5.1 percent. In TRANSCEND-T2D-1 long-term blood sugar (HbA1c) fell by up to 1.94 percentage points in 40 weeks.

What happens to liver fat?

In a substudy with fatty liver (MASLD) liver fat fell by about 81 to 82 percent after 24 weeks in the two higher levels. 86 percent reached normal liver fat below 5 percent at the highest level. A large phase 3 trial on liver disease runs until 2030.

Which side effects were seen?

Most often gastrointestinal effects such as nausea and diarrhoea, depending on the dose. In TRIUMPH-2 abnormal skin sensations (dysaesthesia) and low blood pressure occurred more often than on placebo. In the phase 2 trial heart rate rose in a dose-dependent way, most around week 24.

Which trials are still running?

Nine phase 3 trials are not finished yet. The largest: TRIUMPH-OUTCOMES on heart and kidney events with about 10,000 participants (planned end 2029) and SYNERGY-Outcomes on fatty liver (2030). The comparison with Tirzepatide (TRIUMPH-5) is due to reach its primary endpoint in November 2026.

Porovnania

Porovnanie s ostatnými

Súvisiace

Súvisiace produkty